These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17668875)

  • 1. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
    Persico M; Capasso M; Persico E; Svelto M; Russo R; Spano D; Crocè L; La Mura V; Moschella F; Masutti F; Torella R; Tiribelli C; Iolascon A
    Hepatology; 2007 Oct; 46(4):1009-15. PubMed ID: 17668875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
    Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
    Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
    Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
    Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
    Martinez D; Palmer C; Simar D; Cameron BA; Nguyen N; Aggarwal V; Lloyd AR; Zekry A
    Liver Int; 2015 Feb; 35(2):463-72. PubMed ID: 24461080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    Jian Wu Y; Shu Chen L; Gui Qiang W
    Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
    Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
    World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.
    Pascarella S; Clément S; Dill MT; Conzelmann S; Lagging M; Missale G; Neumann AU; Pawlotsky JM; Zeuzem S; Rubbia-Brandt L; Bochud PY; Negro F
    Liver Int; 2013 Jan; 33(1):94-103. PubMed ID: 23164156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
    Persico M; Capasso M; Russo R; Persico E; Crocè L; Tiribelli C; Iolascon A
    Gut; 2008 Apr; 57(4):507-15. PubMed ID: 17881539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
    Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
    Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome.
    Fattovich G; Baroni GS; Pasino M; Pierantonelli I; Covolo L; Ieluzzi D; Passigato N; Tonon A; Faraci MG; Guido M; Negro F
    Dig Liver Dis; 2012 May; 44(5):419-25. PubMed ID: 22277808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.
    Chen L; Borozan I; Sun J; Guindi M; Fischer S; Feld J; Anand N; Heathcote J; Edwards AM; McGilvray ID
    Gastroenterology; 2010 Mar; 138(3):1123-33.e1-3. PubMed ID: 19900446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
    Dill MT; Makowska Z; Duong FHT; Merkofer F; Filipowicz M; Baumert TF; Tornillo L; Terracciano L; Heim MH
    Gastroenterology; 2012 Sep; 143(3):777-786.e6. PubMed ID: 22677194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.
    Antonucci G; Longo MA; Angeletti C; Vairo F; Oliva A; Comandini UV; Tocci G; Boumis E; Noto P; Solmone MC; Capobianchi MR; Girardi E
    Am J Gastroenterol; 2007 Jul; 102(7):1383-91. PubMed ID: 17403072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
    Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
    Soresi M; Tripi S; Franco V; Giannitrapani L; Alessandri A; Rappa F; Vuturo O; Montalto G
    Liver Int; 2006 Nov; 26(9):1119-25. PubMed ID: 17032413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a.
    Nasta P; Gatti F; Puoti M; Cologni G; Bergamaschi V; Borghi F; Matti A; Ricci A; Carosi G
    AIDS; 2008 Apr; 22(7):857-61. PubMed ID: 18427204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.
    El-Saadany S; Ziada DH; El Bassat H; Farrag W; El-Serogy H; Eid M; Abdallah M; Ghazy M; Salem HA
    Can J Gastroenterol; 2013 Feb; 27(2):e13-7. PubMed ID: 23472246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Saad Y; Ahmed A; Saleh DA; Doss W
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
    AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.